CCM to sell pharmaceutical operations to subsidiary


PETALING JAYA: Chemical Company of Malaysia (CCM) Bhd plans to sell six pharmaceutical units in Malaysia, the Philippines and Singapore to 73.7%-owned subsidiary CCM Duopharma Biotech Bhd for RM133.3mil.

Proceeds from the disposal would be reinvested in its subsidiary, CCM told Bursa Malaysia.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , CCM , CCM Duopharma

   

Next In Business News

Chin Hin taps Ajiya for two-year RM250mil loan
MI Technovation posts three-fold surge in net profit
Inari switches gear to remain relevant
InNature diversifies into the F&B industry
New capacity in the pipeline
Yinson’s RM16bil debt too big to ignore
Leap in operating income for UOB’s retail banking
Paramount emerges as major shareholder in EWI
Coordinated approach crucial to strengthen SMEs
CIMB Securities eyes larger market share

Others Also Read